Sylvain Sachot

Sylvain Sachot has a wealth of work experience. Sylvain began their career in 2009 as a Postdoctoral Researcher at the Icahn School of Medicine at Mount Sinai. In 2014, they moved to the Vall d’Hebron Institute of Research (VHIR) as a Business Analyst. In 2015, they joined Ysios Capital as an Investment Associate. From 2017 to 2019, they held the role of Board Observer at Anaconda BioMed. In 2018, they became a Partner, Principal, and Investment Director at Asabys Partners. In 2019, they added Board Director to their roles at Anaconda BioMed. In 2020, they became a Board Observer at MedLumics, S.L., a Board Director at Splice Bio, and a Board Observer at INBRAIN Neuroelectronics.

Sylvain Sachot obtained a Master of Business Administration (MBA) from Esade in 2014, a PhD in Biology - Biochemistry - Molecular Biology from Nantes Universit\u00e9 between 2004 and 2009, and a Master in Biotechnology from Universit\u00e9 Paris-Est Cr\u00e9teil (UPEC) in 2003-2004. In addition, they obtained a certification in Global Governance and Geopolitics of the 21st Century from Esade Business School in May 2013.